If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssensys Regulatory News (ESYS)

  • There is currently no data for ESYS

AIM Rule 17 Schedule Two paragraph (g) update

16 Jun 2025 18:15

RNS Number : 0695N
essensys PLC
16 June 2025
 

16 June 2025

essensys plc

AIM Rule 17 Schedule Two paragraph (g) update

essensys plc (AIM:ESYS), the leading global provider of software and technology to the flexible workspace industry, announces the following information relating to directors' disclosures under Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

Charles Butler, Non-Executive Director

The following disclosure is made further to the essensys plc admission document dated 23 May 2019.

Current directorships and/or partnerships as at 23 May 2019:

HCP High Yield Commercial Property LLP

Jon Lee, Non-Executive Chairman

The following disclosure is made further to the essensys plc admission document dated 23 May 2019.

Current directorships and/or partnerships as at 23 May 2019

Ffrees Family Finance Limited

Former directorships and/or partnerships as at 23 May 2019

The disclosure regarding Jon Lee's directorship of VLOC Holdings Limited is as follows:

"Jonathan Lee was a director of VLOC Holdings Limited when the members and creditors appointed a liquidator on 1 December 2009 to effect a creditors voluntary liquidation which was completed on 29 July 2010 and dissolved on 29 October 2010."

 

-Ends-

For further information, please contact:

essensys plc 

+44 (0)20 3102 5252

James Lowery, Chief Executive Officer 

Greg Price, Chief Financial Officer

Singer Capital Markets (Nominated Adviser and Broker) 

+44 (0)20 7496 3000 

Peter Steel / James Fischer 

Gracechurch Group 

Heather Armstrong / Alexis Gore / Rebecca Scott

+44 (0) 20 4582 3500

essensys@gracechurchpr.com

 

 

About essensys plc 

Founded in 2006 and listed on the London Stock Exchange AIM Market, essensys is a leading global provider of software and technology to the commercial real estate industry.

Partnering with many of the world's leading landlords and flexible workspace operators, essensys delivers innovative digital experience (DX) solutions that drive occupancy, maximise yield and reduce operating costs. Its flagship products, essensys Platform and elumo, solve the complex challenges of managing physical and digital access in dynamic multi-tenant environments, while delivering deep space utilisation insights and transformative digital experiences.

With a focus on Access, Intelligence & Experience, essensys' products enable real estate leaders to unlock the full potential of their portfolios in today's flexible, hybrid world while ensuring they stay ahead in an era of dynamic workplace evolution.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNGZGMVNVZGKZM
Date   Source Headline
31st Oct 20237:00 amRNSFull year results
23rd Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
19th Oct 20237:00 amRNSNotice of Results
6th Sep 20237:00 amRNSIssue of Equity and Total Voting Rights
31st Aug 20237:00 amRNSFull year trading update
4th Jul 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Mar 20237:00 amRNSHalf year results
22nd Mar 202311:30 amRNSNotice of Results and Investor Presentation
28th Feb 20237:00 amRNSHalf Year Trading Update
6th Dec 20229:37 amRNSHolding(s) in Company
1st Dec 202212:04 pmRNSResult of AGM
1st Dec 20227:00 amRNSAGM Trading Update
7th Nov 20224:00 pmRNSPosting of 2022 Annual Report and Notice of AGM
1st Nov 20227:00 amRNSPublication of Audited Annual Report and Accounts
18th Oct 20227:00 amRNSFULL YEAR RESULTS
14th Oct 20227:00 amRNSNotice of Investor Presentation
26th Sep 20229:30 amRNSNotice of Results
16th Sep 202210:27 amRNSDirector/PDMR Shareholding
24th Aug 20227:00 amRNSFull Year Trading Update
17th May 20227:00 amRNSBoard Changes
9th May 20229:52 amRNSHolding(s) in Company
3rd May 20223:18 pmRNSDirector/PDMR Shareholding
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
22nd Apr 202211:05 amRNSSecond Price Monitoring Extn
22nd Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20229:05 amRNSSecond Price Monitoring Extn
21st Apr 20229:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSHalf-year Report
29th Mar 20227:00 amRNSNotice of Investor Meet Company Presentation
22nd Mar 202210:46 amRNSHolding(s) in Company
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
17th Mar 20225:56 pmRNSDirector/PDMR Shareholding
11th Mar 202210:08 amRNSNotice of Results
10th Mar 202212:31 pmRNSHolding(s) in Company
2nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSTrading Update
7th Feb 20227:00 amRNSAppointment of CEO UK & Europe and PDMR Dealing
3rd Feb 20227:00 amRNSBoard Changes
2nd Dec 202111:20 amRNSResult of AGM
16th Nov 20212:46 pmRNSDirector/PDMR Shareholding
8th Nov 20215:54 pmRNSPosting of Annual Report and Accounts & AGM Notice
25th Oct 20215:04 pmRNSHolding(s) in Company
19th Oct 20217:00 amRNSFull Year Results
15th Oct 20217:00 amRNSNotice of Investor Meet Company Presentation
14th Oct 20217:00 amRNSCustomer Renewal
12th Oct 20219:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.